A novel neoadjuvant approach can essentially cure a disease that often gives patients less than a year to live.
Category: Oncology Innovations
UVA Health is among the first 25 centers to bring cancer patients the MRIdian Linac, a significant advance in MR-guided radiation therapy.
Using cutting-edge genomics technology, UVA Cancer Center researchers uncover patterns of chromatin accessibility in early gut development and reveal critical drivers of gut-related cancers.
See how UVA Health's lung cancer surgeons earned a coveted 3 stars from The Society of Thoracic Surgeons.
No other center has the depth of scientific knowledge & translational research know-how to produce more unprecedented results for rare hematologic malignancies.
Get practice-changing insight from UVA Cancer Center on methotrexate-based CNS prophylaxis for aggressive B-cell lymphoma.
A UVA Health researcher and colleagues have found that a new drug combination may lengthen survival in patients with advanced non-squamous NSCLC.
Discover the new worldwide leader in translational FUS immuno-oncology research.
A team of UVA Health researchers has found evidence that screening for STAT3 mutations will help to better classify and diagnose patients with LGL leukemia.
UVA Health lung cancer specialists will discuss the latest developments in lung cancer management. Bring your questions.